Mosedin 5 mg/5ml syrup 60 ml

Trade name:

Mosedine

Mosedin

Properties

H1-histamine receptor blocker (long-acting). Suppresses the release of histamine and leukotriene C4 from mast cells. Prevents the development and facilitates the course of allergic reactions. It has antiallergic, antipruritic, antiexudative action. Reduces capillary permeability, prevents the development of tissue edema. The antiallergic effect develops within the first 1-3 hours after taking the drug, reaches a maximum within 8-12 hours and lasts 24 hours. It does not affect the central nervous system (because it does not penetrate the blood-brain barrier) and is not addictive.

Indications

Monosedine is indicated for the symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children over 2 years of age weighing more than 30 kg.

Dosage and administration

inside. Can be used with or without food.

Children aged 2 to 12 years weighing less than 30 kg — 5 mg 1 time per day (corresponding to 5 ml of syrup).

Contraindications

Hypersensitivity to the active substance or to any of the auxiliary components of the drug, lactation.

With caution: liver failure, pregnancy.

Precautionary measures:

Side effects

In clinical studies in adults and adolescents, the most common adverse reactions were drowsiness (1.2%), headache (0.6%), increased appetite (0.5%) and insomnia (0.1%).

Storage method:

Store at a temperature not exceeding 25 degrees